LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Zurück zur letzten Suche Suchhistorie
Erweiterte Suche

Ihre letzten Suchen

  1. AU=Gangadaran Sittu Govindasamy Dinakaran
  2. AU="Biceroglu, Huseyin"
  3. AU="Rodriguez Fernandez, G"
  4. AU="Di Petrillo, Amalia"
  5. AU="Sekar Karthik"
  6. AU="Singh Pramod"
  7. AU="Huang, Hsin-Yi"
  8. AU="Dell'Aversana, Carmela"
  9. AU="Vasco, Chiara Maria"
  10. AU="Gad Elkareem, Ashraf M"
  11. AU=Klein Alice
  12. AU=Farah Zayd
  13. AU="Morlock, Glenn P"
  14. AU="Frisch, Andrew T"
  15. AU=Stein Ricardo
  16. AU=Mann J John
  17. AU="Torres-Parejo, Úrsula"
  18. AU="Maccaferri, Monica"
  19. AU=Le Jemtel Thierry H
  20. AU="Xu, Zebin"
  21. AU=Veit Kaleb
  22. AU="Probst, Hans Christian"
  23. AU="Peoples, Jacob"
  24. AU="Cohen, Ehud" AU="Cohen, Ehud"
  25. AU="Ciechanover, Isaac"
  26. AU="Li, Shuyun"
  27. AU="de Oliveira E Silva, Ita"
  28. AU="Wang, Zhishan"
  29. AU="Grandel, Markus"
  30. AU="Abu-Asab, Mones"
  31. AU="Sikorska, Ewa"
  32. AU="Dye, S."
  33. AU="Smith, Jacqueline A M"
  34. AU="Fung, Hoki"
  35. AU="Schilizzi, B M"
  36. AU="Zhang, Nan"
  37. AU="Hu, Zhanggui"
  38. AU=Carty E
  39. AU="Ohki, Yutaro"
  40. AU="Nikolic, Luka"
  41. AU="Chan, Ho-Yin Edwin"
  42. AU="William Tam"
  43. AU="Kitandwe, Paul Kato"
  44. AU="Di Berardino, Chiara"
  45. AU="Li, Changlin"
  46. AU="Poku, Ohemaa"
  47. AU="Fallah, Milad"
  48. AU="Singh, Meetali"
  49. AU="Hickerson K. P."
  50. AU="Arvaniti, Christina"
  51. AU="Lu, Hongxia"

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel: Current Management Options in Metastatic Renal Cell Cancer.

    Gangadaran, Sittu Govindasamy Dinakaran

    Oncology reviews

    2017  Band 11, Heft 2, Seite(n) 339

    Abstract: Renal cancer accounts for 2.4% of all cancers. Localised disease accounts for the majority of renal cancers (70-75%), however 20-25% of these ultimately develop distant metastasis. The median overall survival of un treated metastatic disease is 5 months ... ...

    Abstract Renal cancer accounts for 2.4% of all cancers. Localised disease accounts for the majority of renal cancers (70-75%), however 20-25% of these ultimately develop distant metastasis. The median overall survival of un treated metastatic disease is 5 months with 1-year survival of only 29%. The management of metastatic renal cell cancers traditionally relied on systemic immunotherapy with attendant high morbidity but after the year 2005 the use of effective targeted therapy with tolerable side effect profile has improved the survival from 10.2 months in the cytokine era to 17.7 months. This article reviews the past, present and future options in the management of metastatic renal cancer.
    Sprache Englisch
    Erscheinungsdatum 2017-06-14
    Erscheinungsland Italy
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2390302-8
    ISSN 1970-5565 ; 1970-5565 ; 1970-5557
    ISSN (online) 1970-5565
    ISSN 1970-5565 ; 1970-5557
    DOI 10.4081/oncol.2017.339
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 6550: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel ; Online: Current management options in metastatic renal cell cancer

    Sittu Govindasamy Dinakaran Gangadaran

    Oncology Reviews, Vol 11, Iss

    2017  Band 2

    Abstract: Renal cancer accounts for 2.4% of all cancers. Localised disease accounts for the majority of renal cancers (70-75%), however 20-25% of these ultimately develop distant metastasis. The median overall survival of un treated metastatic disease is 5 months ... ...

    Abstract Renal cancer accounts for 2.4% of all cancers. Localised disease accounts for the majority of renal cancers (70-75%), however 20-25% of these ultimately develop distant metastasis. The median overall survival of un treated metastatic disease is 5 months with 1-year survival of only 29%. The management of metastatic renal cell cancers traditionally relied on systemic immunotherapy with attendant high morbidity but after the year 2005 the use of effective targeted therapy with tolerable side effect profile has improved the survival from 10.2 months in the cytokine era to 17.7 months. This article reviews the past, present and future options in the management of metastatic renal cancer.
    Schlagwörter Renal cancer ; metastatic disease ; targeted therapy ; immunotherapy ; Other systems of medicine ; RZ201-999 ; Internal medicine ; RC31-1245
    Sprache Englisch
    Erscheinungsdatum 2017-06-01T00:00:00Z
    Verlag PAGEPress Publications
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Volltext online

    Zusatzmaterialien

    Kategorien

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Zum Seitenanfang